Evaluating the impact of therapeutic drug monitoring strategies on clinical outcomes in paediatric inflammatory bowel disease
Our data suggest that proactive TDM may offer clinical and pharmacokinetic benefits, particularly for paediatric IBD patients treated with IFX, while results for other outcomes and for ADL were less clear. Prospective studies are needed to confirm these findings and to further clarify the role of proactive TDM in this population.
Authors
- Sebastian Stricker (ORCID: https://orcid.org/0000-0003-1531-3627)
- Jan De Laffolie
- Karlotta Pauline Hubert
Institutions
- Justus-Liebig-Universität Gießen (DE)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1002/jpn3.70396
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00